Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Intra-articular therapies: patient preferences and professional practices in European countries

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

de la Torre-Aboki, J, Uson, J, Pitsillidou, I, Vardanyan, V, Nikiphorou, E, Rodriguez-Garcia, SC, Castellanos-Moreira, R, Pandit, H, O'Neill, TW, Doherty, M, Boesen, M, Möller, I, Terslev, L, D'Agostino, MA, Kampen, WU, Berenbaum, F, Naredo, E & Carmona, L 2022, 'Intra-articular therapies: patient preferences and professional practices in European countries', Rheumatology International, vol. 42, no. 5, pp. 869-878. https://doi.org/10.1007/s00296-021-05045-5

APA

de la Torre-Aboki, J., Uson, J., Pitsillidou, I., Vardanyan, V., Nikiphorou, E., Rodriguez-Garcia, S. C., Castellanos-Moreira, R., Pandit, H., O'Neill, T. W., Doherty, M., Boesen, M., Möller, I., Terslev, L., D'Agostino, M. A., Kampen, W. U., Berenbaum, F., Naredo, E., & Carmona, L. (2022). Intra-articular therapies: patient preferences and professional practices in European countries. Rheumatology International, 42(5), 869-878. https://doi.org/10.1007/s00296-021-05045-5

CBE

de la Torre-Aboki J, Uson J, Pitsillidou I, Vardanyan V, Nikiphorou E, Rodriguez-Garcia SC, Castellanos-Moreira R, Pandit H, O'Neill TW, Doherty M, Boesen M, Möller I, Terslev L, D'Agostino MA, Kampen WU, Berenbaum F, Naredo E, Carmona L. 2022. Intra-articular therapies: patient preferences and professional practices in European countries. Rheumatology International. 42(5):869-878. https://doi.org/10.1007/s00296-021-05045-5

MLA

Vancouver

de la Torre-Aboki J, Uson J, Pitsillidou I, Vardanyan V, Nikiphorou E, Rodriguez-Garcia SC et al. Intra-articular therapies: patient preferences and professional practices in European countries. Rheumatology International. 2022 May;42(5):869-878. https://doi.org/10.1007/s00296-021-05045-5

Author

de la Torre-Aboki, Jenny ; Uson, Jacqueline ; Pitsillidou, Irene ; Vardanyan, Valentina ; Nikiphorou, Elena ; Rodriguez-Garcia, Sebastian C ; Castellanos-Moreira, Raul ; Pandit, Hemant ; O'Neill, Terence W ; Doherty, Michael ; Boesen, Mikael ; Möller, Ingrid ; Terslev, Lene ; D'Agostino, Maria Antonietta ; Kampen, Willm Uwe ; Berenbaum, Francis ; Naredo, Esperanza ; Carmona, Loreto. / Intra-articular therapies : patient preferences and professional practices in European countries. In: Rheumatology International. 2022 ; Vol. 42, No. 5. pp. 869-878.

Bibtex

@article{ae616db9ea6440deb3046a31b4b2a86c,
title = "Intra-articular therapies: patient preferences and professional practices in European countries",
abstract = "To assess patient perspective and professional practice of intraarticular therapies (IATs) across Europe, an expert international multidisciplinary panel designed two open web-based surveys: one targeting people who had experienced at least two IATs (44 items); and one targeting health care providers (HCPs) (160 items). Surveys were disseminated via patient and professional associations and social media. A descriptive analysis was performed. The surveys were answered by 200 patients and 186 HCPs from 26 countries, showing that IAT is routinely performed by rheumatologists (97%) and orthopaedic surgeons (89%), with specific training being compulsory in a few countries. The most frequent indications for IAT are arthritis (76%), osteoarthritis (74%), crystal arthritis (71%) and bursitis (70%); the most frequently injected joints are knee (78%) and shoulder (70%); and the most used compounds are glucocorticoids. The majority of HCPs report informing patients about side-effects (73%), benefits (72%), and the nature of the procedure (72%), which coincides with 27% of patients reporting that they had not been informed about benefits or potential complications of IATs; 73% of patients had not been asked whether they wanted an anaesthetic. Few HCPs (10%) obtain written consent (56% get oral consent, being mandatory for 32%), a procedure deemed necessary by 41% of the patients. 50% of patients reported a clear benefit of IAT and 20% experienced complications including pain, impaired mobility, rashes, or swelling. In summary, the practice of IAT is variable across Europe, and although patients perceive it as relatively safe and usually effective procedure, some gaps were identified.",
keywords = "Clinical practice, Glucocorticoids, Infiltrations, Intraarticular therapies, Patient{\textquoteright}s experience, Surveys",
author = "{de la Torre-Aboki}, Jenny and Jacqueline Uson and Irene Pitsillidou and Valentina Vardanyan and Elena Nikiphorou and Rodriguez-Garcia, {Sebastian C} and Raul Castellanos-Moreira and Hemant Pandit and O'Neill, {Terence W} and Michael Doherty and Mikael Boesen and Ingrid M{\"o}ller and Lene Terslev and D'Agostino, {Maria Antonietta} and Kampen, {Willm Uwe} and Francis Berenbaum and Esperanza Naredo and Loreto Carmona",
note = "{\textcopyright} 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.",
year = "2022",
month = may,
doi = "10.1007/s00296-021-05045-5",
language = "English",
volume = "42",
pages = "869--878",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - Intra-articular therapies

T2 - patient preferences and professional practices in European countries

AU - de la Torre-Aboki, Jenny

AU - Uson, Jacqueline

AU - Pitsillidou, Irene

AU - Vardanyan, Valentina

AU - Nikiphorou, Elena

AU - Rodriguez-Garcia, Sebastian C

AU - Castellanos-Moreira, Raul

AU - Pandit, Hemant

AU - O'Neill, Terence W

AU - Doherty, Michael

AU - Boesen, Mikael

AU - Möller, Ingrid

AU - Terslev, Lene

AU - D'Agostino, Maria Antonietta

AU - Kampen, Willm Uwe

AU - Berenbaum, Francis

AU - Naredo, Esperanza

AU - Carmona, Loreto

N1 - © 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

PY - 2022/5

Y1 - 2022/5

N2 - To assess patient perspective and professional practice of intraarticular therapies (IATs) across Europe, an expert international multidisciplinary panel designed two open web-based surveys: one targeting people who had experienced at least two IATs (44 items); and one targeting health care providers (HCPs) (160 items). Surveys were disseminated via patient and professional associations and social media. A descriptive analysis was performed. The surveys were answered by 200 patients and 186 HCPs from 26 countries, showing that IAT is routinely performed by rheumatologists (97%) and orthopaedic surgeons (89%), with specific training being compulsory in a few countries. The most frequent indications for IAT are arthritis (76%), osteoarthritis (74%), crystal arthritis (71%) and bursitis (70%); the most frequently injected joints are knee (78%) and shoulder (70%); and the most used compounds are glucocorticoids. The majority of HCPs report informing patients about side-effects (73%), benefits (72%), and the nature of the procedure (72%), which coincides with 27% of patients reporting that they had not been informed about benefits or potential complications of IATs; 73% of patients had not been asked whether they wanted an anaesthetic. Few HCPs (10%) obtain written consent (56% get oral consent, being mandatory for 32%), a procedure deemed necessary by 41% of the patients. 50% of patients reported a clear benefit of IAT and 20% experienced complications including pain, impaired mobility, rashes, or swelling. In summary, the practice of IAT is variable across Europe, and although patients perceive it as relatively safe and usually effective procedure, some gaps were identified.

AB - To assess patient perspective and professional practice of intraarticular therapies (IATs) across Europe, an expert international multidisciplinary panel designed two open web-based surveys: one targeting people who had experienced at least two IATs (44 items); and one targeting health care providers (HCPs) (160 items). Surveys were disseminated via patient and professional associations and social media. A descriptive analysis was performed. The surveys were answered by 200 patients and 186 HCPs from 26 countries, showing that IAT is routinely performed by rheumatologists (97%) and orthopaedic surgeons (89%), with specific training being compulsory in a few countries. The most frequent indications for IAT are arthritis (76%), osteoarthritis (74%), crystal arthritis (71%) and bursitis (70%); the most frequently injected joints are knee (78%) and shoulder (70%); and the most used compounds are glucocorticoids. The majority of HCPs report informing patients about side-effects (73%), benefits (72%), and the nature of the procedure (72%), which coincides with 27% of patients reporting that they had not been informed about benefits or potential complications of IATs; 73% of patients had not been asked whether they wanted an anaesthetic. Few HCPs (10%) obtain written consent (56% get oral consent, being mandatory for 32%), a procedure deemed necessary by 41% of the patients. 50% of patients reported a clear benefit of IAT and 20% experienced complications including pain, impaired mobility, rashes, or swelling. In summary, the practice of IAT is variable across Europe, and although patients perceive it as relatively safe and usually effective procedure, some gaps were identified.

KW - Clinical practice

KW - Glucocorticoids

KW - Infiltrations

KW - Intraarticular therapies

KW - Patient’s experience

KW - Surveys

UR - http://www.scopus.com/inward/record.url?scp=85115114160&partnerID=8YFLogxK

U2 - 10.1007/s00296-021-05045-5

DO - 10.1007/s00296-021-05045-5

M3 - Journal article

C2 - 34761277

VL - 42

SP - 869

EP - 878

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 5

ER -

ID: 70411021